Evidence map›Paper›PMID 32010640›Full record

ReviewFrontiers in cellular and infection microbiology2019

How Probiotics Affect the Microbiota.

Grégoire Wieërs, Leila Belkhir, Raphaël Enaud, Sophie Leclercq, Jean-Michel Philippart de Foy, Isabelle Dequenne, Philippe de Timary, Patrice D Cani

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07694791 (Impact of Synbiotic Supplementation in Peritoneal Dialysis Patients), which is not on this map. Cited by 276 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
276citing papers in PubMed, 9 pooled it
23.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07694791 narecruitingnot on this mapstarted 2025, after this paper: background citation

Impact of Synbiotic Supplementation in Peritoneal Dialysis Patients

TypeinterventionalSponsorHospital Universitario Dr. Jose E. GonzalezRan2025 to 2027Enrolled60ConditionsChronic Kidney Disease (Stages 4 and 5), Peritoneal Dialysis (PD)ArmsSynbiotic, Placebo
3 · Its place in the literature

Who cites it

276 citing papers in PubMed, 9 syntheses or guidelines pooled it, 524 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Nutrients · 2025
    Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

216 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Grégoire WieërsService de Médecine Interne Générale, Clinique Saint Pierre, Ottignies, Belgium.
Leila BelkhirService de Médecine Interne et Maladies Infectieuses, Cliniques Universitaires Saint Luc, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.
Raphaël EnaudCHU Bordeaux, CRCM Pédiatrique, CIC 1401, Université de Bordeaux, INSERM, CRCTB, U1045, CHU Bordeaux, Bordeaux, France.
Sophie LeclercqInstitute of Neuroscience and Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.
Jean-Michel Philippart de FoySociété Scientifique de Médecine Générale, Cellule Nutrition, Brussels, Belgium.
Isabelle DequenneSociété Royale Belge de Dermatologie, Brussels, Belgium.
Philippe de TimaryService de Psychiatrie, Cliniques Universitaires Saint Luc, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.
Patrice D CaniWalloon Excellence in Life Sciences and BIOtechnology, Metabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.
Cliniques Universitaires Saint-Luc · BEUCLouvain · BEClinique Saint Pierre · BEMédecins du Monde · BEUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotics have been used to treat a variety of diseases for decades; however, what is the rationale for their application? Such a treatment was first proposed in the early nineteenth century based on observations of decreased bifidobacterial populations in children suffering from diarrhea, suggesting that oral intake of bifidobacteria could replete this subpopulation of the microbiota and improve health. Since then, studies have shown modifications in the gut or skin microbiota in the course of a variety of diseases and suggested positive effects of certain probiotics. Most studies failed to report any impact on the microbiota. The impact of probiotics as well as of bacteria colonizing food does not reside in their ability to graft in the microbiota but rather in sharing genes and metabolites, supporting challenged microbiota, and directly influencing epithelial and immune cells. Such observations argue that probiotics could be associated with conventional drugs for insulin resistance, infectious diseases, inflammatory diseases, and psychiatric disorders and could also interfere with drug metabolism. Nevertheless, in the context of a plethora of probiotic strains and associations produced in conditions that do not allow direct comparisons, it remains difficult to know whether a patient would benefit from taking a particular probiotic. In other words, although several mechanisms are observed when studying a single probiotic strain, not all individual strains are expected to share the same effects. To clarify the role of probiotics in the clinic, we explored the relation between probiotics and the gut and skin microbiota.

Indexed as

AnimalsAnti-Bacterial AgentsBacteriaBifidobacteriumChildDiarrheaDrug InteractionsDrug Resistance, BacterialGastrointestinal MicrobiomeHumansProbioticsPsychiatryPsychopathologyAnti-Bacterial Agentsclinicsdrug interactionmetabolismmicrobiotaprobioticpsychiatryskin

Identifiers

PMID32010640
PMCPMC6974441
OpenAlexW2999173212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.